New gel aims to reduce painful scarring after back surgery

NCT ID NCT06369233

Ongoing Disease control Sponsor: L&C Bio Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new gel, MegaShield-SP, to see if it prevents scar tissue after spine surgery better than an existing gel. About 80 adults aged 20-70 with a herniated disc or spinal stenosis will receive one of the two gels during surgery. Researchers will measure scar formation on MRI and track pain and disability over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HERNIATION, DISC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Intervertebral Disc Displacement lumbar disk herniation, susceptibility to spinal stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HERNIATION, DISC

Contacts and locations

Locations

Bundang Seoul National University Hospital

Seongnam-si, 13620, South Korea
Eunpyeong ST. Mary's Hospital

Seoul, 03312, South Korea
Gangnam Severance Hospital

Seoul, 06273, South Korea
Severance Hospital

Seoul, 03722, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.